EMILY BARTON: Open Payments
NPI 1790484434 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 33 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $122 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $115 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| ABBVIE INC. | 2 | $57 |
| Amgen Inc. | 2 | $38 |
| Indivior Inc. | 2 | $32 |
| Abbott Laboratories | 1 | $25 |
| Exact Sciences Corporation | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $23 |
Products named: REXULTI, SHINGRIX, PREVNAR 20, VRAYLAR, NURTEC ODT, NEXIUM, SUBLOCADE, FREESTYLE LIBRE 3.
Industry payments across CO — which companies pay providers there.
